Lung Cancer Diagnostic Tests Market Report

Global Lung Cancer Diagnostic Tests Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 25, 2020
  • PAGES：215
  • REPORT CODE：GMM582412
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.

    The Lung Cancer Diagnostic Tests is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The research provides insights for the global Lung Cancer Diagnostic Tests market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Lung Cancer Diagnostic Tests industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Lung Cancer Diagnostic Tests Market Segmentations:

    By Players:

    • Advpharma Inc

    • Emory Healthcare Austrian Institute of Technology GmbH

    • Quest Diagnostics

    • BioMarker Strategies LLC

    • Emory University

    • Mayo Clinic

    • Epigenomics AG

    • GlycoZym SAS

    • Courtagen Life Sciences Inc US

    By Types:

    • Immunoassays

    • Flow Cytometry

    • Rapid Tests

    • Molecular Assays

    • Tissue Arrays

    • Circulating Tumor Cells

    • Pharmacodiagnostics

    • Biomarkers

    • Other Diagnostics Methods

    By End-User:

    • Precision Medicine

    • Personalized Medicine

    • Cancer Monitoring

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Lung Cancer Diagnostic Tests Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

      • 1.3.2 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

      • 1.3.3 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

      • 1.3.4 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

      • 1.3.5 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

      • 1.3.6 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

      • 1.3.7 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

      • 1.3.8 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

      • 1.3.9 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2014 to 2026

      • 1.4.2 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

      • 1.4.3 Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Lung Cancer Diagnostic Tests Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Lung Cancer Diagnostic Tests by Major Types

      • 3.4.1 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays

      • 3.4.2 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry

      • 3.4.3 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests

      • 3.4.4 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays

      • 3.4.5 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays

      • 3.4.6 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells

      • 3.4.7 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics

      • 3.4.8 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers

      • 3.4.9 Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods

    4 Segmentation of Lung Cancer Diagnostic Tests Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Lung Cancer Diagnostic Tests by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Precision Medicine

      • 4.4.2 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Personalized Medicine

      • 4.4.3 Market Size and Growth Rate of Lung Cancer Diagnostic Tests in Cancer Monitoring

    5 Market Analysis by Major Regions

    • 5.1 Global Lung Cancer Diagnostic Tests Production Analysis by Major Regions

    • 5.2 Global Lung Cancer Diagnostic Tests Consumption Analysis by Major Regions

    • 5.3 Global Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    6 Product Commodity of Lung Cancer Diagnostic Tests Market in Major Countries

    • 6.1 Top 5 Export Countries in Lung Cancer Diagnostic Tests market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Lung Cancer Diagnostic Tests market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Lung Cancer Diagnostic Tests Landscape Analysis

    • 7.1 North America Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 7.2 North America Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 7.3 North America Lung Cancer Diagnostic Tests Landscape Analysis by Major Countries

      • 7.3.1 United States Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 7.3.2 Canada Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 7.3.3 Mexico Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    8 Europe Lung Cancer Diagnostic Tests Landscape Analysis

    • 8.1 Europe Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 8.2 Europe Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 8.3 Europe Lung Cancer Diagnostic Tests Landscape Analysis by Major Countries

      • 8.3.1 Germany Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.2 UK Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.3 France Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.4 Italy Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.6 Spain Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.7 Belgium Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.8 Poland Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.9 Russia Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 8.3.10 Turkey Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    9 Asia Pacific Lung Cancer Diagnostic Tests Landscape Analysis

    • 9.1 Asia Pacific Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 9.2 Asia Pacific Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Lung Cancer Diagnostic Tests Landscape Analysis by Major Countries

      • 9.3.1 China Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 9.3.2 Japan Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 9.3.4 India Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 9.3.6 South Korea Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 10.3.2 Brazil Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 10.3.3 Nigeria Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 10.3.4 South Africa Lung Cancer Diagnostic Tests Market Volume and Growth Rate 

      • 10.3.5 Argentina Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Advpharma Inc

      • 11.1.1 Advpharma Inc Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Emory Healthcare Austrian Institute of Technology GmbH

      • 11.2.1 Emory Healthcare Austrian Institute of Technology GmbH Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Quest Diagnostics

      • 11.3.1 Quest Diagnostics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 BioMarker Strategies LLC

      • 11.4.1 BioMarker Strategies LLC Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Emory University

      • 11.5.1 Emory University Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Mayo Clinic

      • 11.6.1 Mayo Clinic Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Epigenomics AG

      • 11.7.1 Epigenomics AG Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 GlycoZym SAS

      • 11.8.1 GlycoZym SAS Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Courtagen Life Sciences Inc US

      • 11.9.1 Courtagen Life Sciences Inc US Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 80 Figures and 187 Tables)

    • Figure Product Picture

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2014 to 2026

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Global Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Lung Cancer Diagnostic Tests Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Lung Cancer Diagnostic Tests Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Lung Cancer Diagnostic Tests

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Immunoassays

    • Figure Market Size and Growth Rate of Flow Cytometry

    • Figure Market Size and Growth Rate of Rapid Tests

    • Figure Market Size and Growth Rate of Molecular Assays

    • Figure Market Size and Growth Rate of Tissue Arrays

    • Figure Market Size and Growth Rate of Circulating Tumor Cells

    • Figure Market Size and Growth Rate of Pharmacodiagnostics

    • Figure Market Size and Growth Rate of Biomarkers

    • Figure Market Size and Growth Rate of Other Diagnostics Methods

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Precision Medicine

    • Figure Market Size and Growth Rate of Personalized Medicine

    • Figure Market Size and Growth Rate of Cancer Monitoring

    • Table Global Lung Cancer Diagnostic Tests Production by Major Regions

    • Table Global Lung Cancer Diagnostic Tests Production Share by Major Regions

    • Figure Global Lung Cancer Diagnostic Tests Production Share by Major Regions in 2014

    • Figure Global Lung Cancer Diagnostic Tests Production Share by Major Regions in 2018

    • Figure Global Lung Cancer Diagnostic Tests Production Share by Major Regions in 2026

    • Table Global Lung Cancer Diagnostic Tests Consumption by Major Regions

    • Table Global Lung Cancer Diagnostic Tests Consumption Share by Major Regions

    • Figure Global Lung Cancer Diagnostic Tests Consumption Share by Major Regions in 2014

    • Figure Global Lung Cancer Diagnostic Tests Consumption Share by Major Regions in 2018

    • Figure Global Lung Cancer Diagnostic Tests Consumption Share by Major Regions in 2026

    • Table North America Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Europe Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Lung Cancer Diagnostic Tests market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table North America Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table North America Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table North America Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table North America Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table North America Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2014

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2018

    • Figure North America Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2026

    • Figure United States Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Europe Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2014

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2018

    • Figure Europe Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2026

    • Figure Germany Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure France Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2026

    • Figure China Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandLung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure India Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Lung Cancer Diagnostic Tests Consumption Share by Major Countries in 2026

    • Figure GCC Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Advpharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advpharma Inc

    • Figure Sales and Growth Rate Analysis of Advpharma Inc

    • Figure Revenue and Market Share Analysis of Advpharma Inc

    • Table Product and Service Introduction of Advpharma Inc

    • Table Company Profile and Development Status of Emory Healthcare Austrian Institute of Technology GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emory Healthcare Austrian Institute of Technology GmbH

    • Figure Sales and Growth Rate Analysis of Emory Healthcare Austrian Institute of Technology GmbH

    • Figure Revenue and Market Share Analysis of Emory Healthcare Austrian Institute of Technology GmbH

    • Table Product and Service Introduction of Emory Healthcare Austrian Institute of Technology GmbH

    • Table Company Profile and Development Status of Quest Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics

    • Figure Revenue and Market Share Analysis of Quest Diagnostics

    • Table Product and Service Introduction of Quest Diagnostics

    • Table Company Profile and Development Status of BioMarker Strategies LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioMarker Strategies LLC

    • Figure Sales and Growth Rate Analysis of BioMarker Strategies LLC

    • Figure Revenue and Market Share Analysis of BioMarker Strategies LLC

    • Table Product and Service Introduction of BioMarker Strategies LLC

    • Table Company Profile and Development Status of Emory University

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emory University

    • Figure Sales and Growth Rate Analysis of Emory University

    • Figure Revenue and Market Share Analysis of Emory University

    • Table Product and Service Introduction of Emory University

    • Table Company Profile and Development Status of Mayo Clinic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mayo Clinic

    • Figure Sales and Growth Rate Analysis of Mayo Clinic

    • Figure Revenue and Market Share Analysis of Mayo Clinic

    • Table Product and Service Introduction of Mayo Clinic

    • Table Company Profile and Development Status of Epigenomics AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epigenomics AG

    • Figure Sales and Growth Rate Analysis of Epigenomics AG

    • Figure Revenue and Market Share Analysis of Epigenomics AG

    • Table Product and Service Introduction of Epigenomics AG

    • Table Company Profile and Development Status of GlycoZym SAS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlycoZym SAS

    • Figure Sales and Growth Rate Analysis of GlycoZym SAS

    • Figure Revenue and Market Share Analysis of GlycoZym SAS

    • Table Product and Service Introduction of GlycoZym SAS

    • Table Company Profile and Development Status of Courtagen Life Sciences Inc US

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Courtagen Life Sciences Inc US

    • Figure Sales and Growth Rate Analysis of Courtagen Life Sciences Inc US

    • Figure Revenue and Market Share Analysis of Courtagen Life Sciences Inc US

    • Table Product and Service Introduction of Courtagen Life Sciences Inc US


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US